Warady Receives 2019 ASPN Founder's Award
Bradley Warady, MD, Division Director-Pediatric Nephrology and Director-Dialysis and Transplantation, Children's Mercy Kansas City, has won the 2019 Founder’s Award from the American Society of Pediatric Nephrology (ASPN).
ASPN began bestowing the Founder’s Award in 1996 to recognize individuals who have made a unique and lasting contribution to the field of Pediatric Nephrology. Nominations are made by ASPN membership and the recipient is selected by an ASPN awards committee. The purpose of the ASPN is to advance the knowledge of pediatric nephrology and foster the dissemination of this knowledge through national scientific meetings and cooperation with other societies concerned with pediatrics and nephrology.
In its award announcement, ASPN noted that Dr. Warady is an international expert in pediatric dialysis, senior editor of two authoritative textbooks, Pediatric Dialysis and Pediatric Dialysis Case Studies, a lead faculty member of the SCOPE collaborative, and Co-Principal Investigator of both the Chronic Kidney Disease in Children (CKiD) study and the International Pediatric Dialysis Network (IPDN). He has served on the ASPN Council and a number of committees, and is a national board member for the National Kidney Foundation (NKF).
Dr. Warady has published more than 450 articles and book chapters. He established Camp ChiMer for transplant recipients and dialysis patients 32 years ago and he has been actively involved with the Ronald McDonald House Charities of Kansas City for more than 25 years.
Dr. Warady has been the recipient of numerous other prestigious awards during his career, including the 2013 NKF J. Michael Lazarus Award, recognizing professionals who have enhanced the clinical practice of dialysis and care of patients with chronic kidney disease, and whose research has yielded novel insights related to renal replacement therapy; the 2015 Henry L. Barnett Award for outstanding teaching and clinical care for children with kidney disease, bestowed by the American Academy of Pediatrics (AAP) Section on Nephrology; and the Patrick and Virginia Clune Award of Excellence by the National Kidney Foundation (NKF) of Kansas and Western Missouri.
Dr. Warady will be presented with the ASPN Founder’s Award at the ASPN awards luncheon in Baltimore on April 27, 2019.
Children’s Mercy Kansas City is an independent, non-profit, 390-bed pediatric health system, providing over half a million patient encounters each year for children from across the country. Children’s Mercy is ranked by U.S. News & World Report in all ten specialties. We have received Magnet® recognition five times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City, our faculty of nearly 800 pediatric specialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatricians and pediatric subspecialists. The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with nationally recognized expertise in genomic medicine, precision therapeutics, population health, health care innovation and emerging infections. In 2021 the CMRI moved into a nine-story, 375,000-square-foot space emphasizing a translational approach to research in which clinicians and researchers work together to accelerate the pace of discovery that enhances care.